Cremerius U - Search Results

1

[Quantification of repositioning errors in PET studies through superimposition of emission and transmission scans. Comparison between acquisition with and without repositioning].

Reinartz P, Zimny M, Cremerius U, Sabri O, Kaiser HJ, Nowak B, Büll U. Reinartz P, et al. Among authors: cremerius u. Nuklearmedizin. 1999;38(6):192-8. Nuklearmedizin. 1999. PMID: 10510803 German.

2

[18F-fluorodeoxyglucose PET in ovarian carcinoma: methodology and preliminary results].

Zimny M, Schröder W, Wolters S, Cremerius U, Rath W, Büll U. Zimny M, et al. Among authors: cremerius u. Nuklearmedizin. 1997 Oct;36(7):228-33. Nuklearmedizin. 1997. PMID: 9441281 German.

3

[Comparison of findings with 18-FDG PET and CT in pretherapeutic staging of malignant lymphoma].

Thill R, Neuerburg J, Fabry U, Cremerius U, Wagenknecht G, Hellwig D, Osieka R, Günther R, Büll U. Thill R, et al. Among authors: cremerius u. Nuklearmedizin. 1997 Oct;36(7):234-9. Nuklearmedizin. 1997. PMID: 9441282 German.

4

[Clinical value of FDG PET for therapy monitoring of malignant lymphoma--results of a retrospective study in 72 patients].

Cremerius U, Fabry U, Kröll U, Zimny M, Neuerburg J, Osieka R, Büll U. Cremerius U, et al. Nuklearmedizin. 1999;38(1):24-30. Nuklearmedizin. 1999. PMID: 9987778 German.

5

F-18-FDG positron imaging in oncological patients: gamma camera coincidence detection versus dedicated PET.

Zimny M, Kaiser HJ, Cremerius U, Sabri O, Schreckenberger M, Reinartz P, Büll U. Zimny M, et al. Among authors: cremerius u. Nuklearmedizin. 1999;38(4):108-14. Nuklearmedizin. 1999. PMID: 10392375

6

Dual-head gamma camera 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography in oncological patients: effects of non-uniform attenuation correction on lesion detection.

Zimny M, Kaiser HJ, Cremerius U, Reinartz P, Schreckenberger M, Sabri O, Buell U. Zimny M, et al. Among authors: cremerius u. Eur J Nucl Med. 1999 Aug;26(8):818-23. doi: 10.1007/s002590050454. Eur J Nucl Med. 1999. PMID: 10436193

7

[Bone scintigraphy and rhenium radioisotope management in the course of metastatic prostatic cancer].

Ostwald E, Sabri O, Cremerius U, Jakse G, Büll U. Ostwald E, et al. Among authors: cremerius u. Nuklearmedizin. 1999;38(7):302-5. Nuklearmedizin. 1999. PMID: 10599071 German.

8

Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI.

Nowak B, Di Martino E, Jänicke S, Cremerius U, Adam G, Zimny M, Reinartz P, Büll U. Nowak B, et al. Among authors: cremerius u. Nuklearmedizin. 1999;38(8):312-8. Nuklearmedizin. 1999. PMID: 10615664

9

Benign versus malignant osseous lesions in the lumbar vertebrae: differentiation by means of bone SPET.

Reinartz P, Schaffeldt J, Sabri O, Zimny M, Nowak B, Ostwald E, Cremerius U, Buell U. Reinartz P, et al. Among authors: cremerius u. Eur J Nucl Med. 2000 Jun;27(6):721-6. doi: 10.1007/s002590050568. Eur J Nucl Med. 2000. PMID: 10901460

10

Optimizing ventilation-perfusion lung scintigraphy: parting with planar imaging.

Reinartz P, Schirp U, Zimny M, Sabri O, Nowak B, Schäfer W, Cremerius U, Büll U. Reinartz P, et al. Among authors: cremerius u. Nuklearmedizin. 2001 Apr;40(2):38-43. Nuklearmedizin. 2001. PMID: 11354986

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters